Where is the Place of Surgery for N2 Disease?

被引：0
|
作者：
Van Schil, Paul [1 ]
Faivre-Finn, Corinne [2 ,3 ]
机构：
[1] Antwerp Univ Hosp, Thorac & Vasc Surg, Antwerp, Belgium
[2] Univ Manchester, Radiotherapy Res Related, Manchester, Lancs, England
[3] Christie NHS Fdn Trust, Manchester, Lancs, England
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
induction therapy; Chemo-radiotherapy; Surgery; stage IIIA-N2 disease; CELL LUNG-CANCER; SALVAGE SURGERY; RADIOTHERAPY; CHEMOTHERAPY; GUIDELINES;
D O I：
10.1016/j.jtho.2016.11.138
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MTE05.01
引用
收藏
页码：S152 / S154
页数：3
相关论文
共 50 条
  • [41] Neoadjuvant chemoradiation and surgery improves survival outcomes compared with definitive chemoradiation in the treatment of stage IIIA N2 non-small-cell lung cancer
    Darling, Gail E.
    Li, Fei
    Patsios, Demetris
    Massey, Christine
    Wallis, Adam G.
    Coate, Linda
    Keshavjee, Shaf
    Pierre, Andrew
    De Perrot, Marc
    Yasufuku, Kazuhiro
    Cypel, Marcelo
    Waddell, Tom
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2015, 48 (05) : 684 - 690
  • [42] Five-year survival analysis and prognostic factors in patients operated on for non-small cell lung cancer with N2 disease
    Lochowski, Mariusz
    Lochowska, Barbara
    Rebowski, Marek
    Brzezinski, Daniel
    Cieslik-Wolski, Bartosz
    Kozak, Jozef
    JOURNAL OF THORACIC DISEASE, 2018, 10 (06) : 3180 - 3186
  • [43] True Prevalence of Unforeseen N2 Disease in NSCLC: A Systematic Review plus Meta-Analysis
    Hui, Wing Kea
    Charaf, Zohra
    Hendriks, Jeroen M. H.
    Van Schil, Paul E.
    CANCERS, 2023, 15 (13)
  • [44] Surgical-decision making in the setting of unsuspected N2 disease: a cost-effectiveness analysis
    Mitzman, Brian
    Varghese Jr, Thomas K.
    Akerley, Wallace L.
    Nelson, Richard E.
    JOURNAL OF THORACIC DISEASE, 2024, 16 (02) : 1063 - 1073
  • [45] What Is the Accuracy of Clinical Staging for Stage III-Single-station N2 NSCLC? A Multi-Centre UK Study
    Craig, Christopher
    Johnston, Janet
    Goodley, Patrick
    Bishop, Paul
    Al-Najjar, Haider
    Brown, Louise
    Gallagher, Joanna
    Sundar, Ramachandran
    Upperton, Sara
    Callister, Matthew
    Meek, David
    Succony, Laura
    Parvez, Wadood
    Tufail, Muhammad
    Jayasekera, Geeshath
    Maclay, John
    Livesey, Alana
    Woolhouse, Ian
    Smith, Natalie
    Bibby, Anna
    Evison, Matthew
    JTO CLINICAL AND RESEARCH REPORTS, 2024, 5 (08):
  • [46] Where and how does training of minimal invasive surgery take place?
    Keller, R
    Bruch, HP
    Schwandner, O
    CHIRURGISCHE GASTROENTEROLOGIE, 2004, 20 : 3 - 6
  • [47] Multimodality Treatment With Surgery for Locally Advanced Non-Small-Cell Lung Cancer With N2 Disease: A Review Article
    Toyokawa, Gouji
    Takenoyama, Mitsuhiro
    Ichinose, Yukito
    CLINICAL LUNG CANCER, 2015, 16 (01) : 6 - 14
  • [48] Ergebnisse der N1- und N2-Chirurgie beim nichtkleinzelligen LungenkarzinomResults of N1 and N2 surgery in non-small cell lung cancer
    J. Pfannschmidt
    J. Kollmeier
    Der Chirurg, 2019, 90 (12): : 974 - 981
  • [49] Trends and Outcomes in Minimally Invasive Surgery for Locally Advanced Non-Small-Cell Lung Cancer With N2 Disease
    Herb, Joshua N.
    Kindell, Daniel G.
    Strassle, Paula D.
    Stitzenberg, Karyn B.
    Haithcock, Benjamin E.
    Mody, Gita N.
    Long, Jason M.
    SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 2021, 33 (02) : 547 - 555
  • [50] Strategy for N2 NSCLC
    Putnam, J.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S1618 - S1619
12345